Russia finishes clinical preliminaries of second potential COVID-19 immunization

Overview

• Post By : Kumar Jeetendra


• Source: Reuters


• Date: 30 Sep,2020

Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia’s Vector Institute, the RIA news agency mentioned Russian customer safety watchdog Rospotrebnadzor as saying on Wednesday

The institute completed early-stage human trials, known as Phase II, earlier this month.